Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Pharmaceutical Holding Company Ltd (NY: BHVN )

85.19 USD +2.04 (+2.46%)
Streaming Delayed Price Updated: 3:37 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biohaven Pharmaceutical Holding Company Ltd

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Biohaven To Report Fourth Quarter And Full Year 2020 Financial Results And Recent Business Developments On March 1, 2021
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and... 
From PR Newswire
Biohaven Pharma's BHV-1200 Effective In Neutralizing COVID-19 Variants
Biohaven Pharmaceutical Holding Co Ltd's(NYSE:BHVN) hyperimmune globulin mimic developed with Biohaven's MATE ... 
Tags News Biotech COVID/19 Coronavirus
From Benzinga
Biohaven's BHV-1200, A Multimodal Antibody Therapy Enhancer (MATE), Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19
-Biohaven's proprietary MATE™ conjugation platform has been used to generate a new class of antibody-based therapies to target COVID-19 
From PR Newswire
Biohaven Provides Update On ESG Practices
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the "Company" or "Biohaven"), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates today announced the... 
From PR Newswire
Biohaven Pharmaceutical Holding Larger Than S&P 500 Component Ralph Lauren
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Biohaven Pharmaceutical Holding Co Ltd (BHVN) was identified as having a larger market cap than the smaller... 
Tags Stocks
From Market News Video
Stocks With Rising Relative Strength: BiohavenPharmaHldg
A Relative Strength Rating upgrade for BiohavenPharmaHldg shows improving technical performance. Will it continue? 
From Investor's Business Daily
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private... 
From Business Wire News Releases
Biohaven Announces Preliminary 4Q2020 Net Product Revenue For NURTEC® ODT
- NURTEC® ODT achieved preliminary net product revenue of approximately $35 million for the fourth quarter of 2020, representing an approximately 98% increase from the prior quarter 
From PR Newswire
Notable Tuesday Option Activity: BHVN, CMG, IRBT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total volume of 10,210... 
Tags Stocks
From Market News Video
Biohaven Dives After Experimental Alzheimer's Treatment Flops In Key Test
Biohaven Pharmaceuticals said Monday its experimental Alzheimer's treatment, known as troriluzole, failed during a midstage testing process. The news sent BHVN stock into a dive Tuesday. 
From Investor's Business Daily
Why Biohaven Pharmaceutical Stock Is Tanking Today
Alzheimer's claims another drug candidate. 
Tags BHVN Market News
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Tenax Therapeutics (NASDAQ:TENX) shares moved upwards by 75.28% to $3.12 during Tuesday's pre-market ... 
Tags NVCN Movers DBVT
From Benzinga
Biohaven Signs Cody Ware as Driver for Nurtec® ODT Chevrolet for the 2021 NASCAR Cup Series Season
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Cody Ware will pilot the Nurtec® ODT (rimegepant) #51 Chevrolet Camaro for Rick Ware Racing during the 2021 NASCAR Cup Series season. The first... 
From PR Newswire
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that it has completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical trial of... 
From PR Newswire
BiohavenPharmaHldg Meets 80-Plus Relative Strength Rating Benchmark
BiohavenPharmaHldg sees its Relative Strength Rating move into the 80-plus level. 
From Investor's Business Daily
Cramer Advises Viewers On Autodesk, Inseego And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Autodesk, Inc. (NASDAQ: ADSK) is one of the best run companies in ... 
Tags ADSK CNBC Benzinga
From Benzinga
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
- Acquires full ownership of Kleo Pharmaceuticals with two novel immune modulating platforms: the Multi-targeted Antibody Therapy Enhancer (MATE™) conjugation platform and Antibody Recruiting Molecule... 
From PR Newswire
Biohaven Pharmaceutical Holding Enters Oversold Territory (BHVN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Biohaven's Nurtec® ODT Partners with Rick Ware Racing for 24 Hours of Daytona Entry
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec® ODT (rimegepant) will be the primary sponsor on the #51 Ligier JS P217 entry into the LMP2 class of the 2021 24 Hours of Daytona.... 
From PR Newswire
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
- Recently completed Phase 2 proof of concept study showed drug signal for troriluzole augmentation in OCD and pivotal Phase 3 trial now initiated 
From PR Newswire
Notable Tuesday Option Activity: BHVN, GS, MKSI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total of 5,088 contracts have traded... 
Tags Stocks
From Market News Video
Noteworthy Wednesday Option Activity: AMED, RPD, BHVN
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Amedisys, Inc. (AMED), where a total of 851 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Biohaven's Rimegepant For Preventive Treatment Of Migraine Published In The Lancet
- Rimegepant 75 mg, already approved for the acute treatment of migraine, demonstrated efficacy and safety for the preventive treatment of migraine in this pivotal Phase 3 trial in adults 
From PR Newswire
Benzinga's Top Upgrades, Downgrades For December 15, 2020
Upgrades According to Wells Fargo, the prior rating for Zynga Inc (NASDAQ: ZNGA) was changed from Equal-Weight to Overweight. ... 
Tags MDT LHX CNHI
From Benzinga
Kleo Pharmaceuticals Presents Preclinical Data on KPMW135, a Novel CD3 x CD20 Bispecific Version of Rituximab, Showing Increased Anti-Tumor Activity Compared to Rituximab, at The 62nd Annual American
Proof-of-Concept Data Demonstrates Broad Therapeutic Potential of Company’s Multi-targeted Antibody Therapy Enhancer (MATE™) Platform 
From GlobeNewswire News Releases
Biohaven's Nurtec™ ODT Partners with the Rick Ware Racing Team in the 2021 NASCAR Cup Series
Biohaven Pharmaceuticals (NYSE:BHVN) announces today that Nurtec™ ODT (rimegepant) will be the primary partner for the No. 51 Rick Ware Racing entry during the entire 2021 NASCAR Cup Series Season,... 
From PR Newswire
Notable Tuesday Option Activity: BHVN, NDLS, DOCU
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biohaven Pharmaceutical Holding Co Ltd (BHVN), where a total volume of 10,889... 
Tags Stocks
From Market News Video
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
- Biohaven acquires exclusive global rights to a portfolio of novel, small-molecule CGRP antagonists 
From PR Newswire
Kleo Pharmaceuticals Announces Data Presentation on KPMW135, a Novel CD3 x CD20 Bispecific Molecule, and Conjugation Platform (MATE™) at The 62nd Annual Society of Hematology (ASH) Meeting
From GlobeNewswire News Releases
Notable Insider Buys In The Past Week: Biglari, Coty, Danaher, Foot Locker, And More
Though buy windows remain closed for some insiders, plenty of others continued to purchase shares despite some market volatility and economic uncertainty. Here are some of the most noteworthy insider... 
Tags Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account